ES2245776T3 - Procedimiento de cultivo in vitro de diferentes estadios de parasitos tisulares. - Google Patents

Procedimiento de cultivo in vitro de diferentes estadios de parasitos tisulares.

Info

Publication number
ES2245776T3
ES2245776T3 ES94916287T ES94916287T ES2245776T3 ES 2245776 T3 ES2245776 T3 ES 2245776T3 ES 94916287 T ES94916287 T ES 94916287T ES 94916287 T ES94916287 T ES 94916287T ES 2245776 T3 ES2245776 T3 ES 2245776T3
Authority
ES
Spain
Prior art keywords
forms
medium
amastigote
culture
promastigote
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94916287T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Loup Lemesre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Application granted granted Critical
Publication of ES2245776T3 publication Critical patent/ES2245776T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES94916287T 1993-05-13 1994-05-13 Procedimiento de cultivo in vitro de diferentes estadios de parasitos tisulares. Expired - Lifetime ES2245776T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9305779 1993-05-13
FR9305779A FR2705358B1 (fr) 1993-05-13 1993-05-13 Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques.

Publications (1)

Publication Number Publication Date
ES2245776T3 true ES2245776T3 (es) 2006-01-16

Family

ID=9447092

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94916287T Expired - Lifetime ES2245776T3 (es) 1993-05-13 1994-05-13 Procedimiento de cultivo in vitro de diferentes estadios de parasitos tisulares.

Country Status (8)

Country Link
US (4) US6458581B1 (https=)
EP (1) EP0698099B1 (https=)
AU (1) AU6800094A (https=)
CA (1) CA2162555C (https=)
DE (2) DE69434424T2 (https=)
ES (1) ES2245776T3 (https=)
FR (2) FR2705358B1 (https=)
WO (1) WO1994026899A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9503451A (pt) * 1995-07-26 1997-09-30 Mendes Rodolfo Pereira Processo de preparação de um antígeno derivado de um mocroorganismo causador de doença infecciosa e/ou parasitária processo de preparação de um antígeno de T cruzi antígeno derivado de midroorganismo causador de doença infecciosa e/ou parasitária antígeno derivado de T cruzi causador de doença de chagas composição a base de um antígeno derivado de microorganismo causador de doença infecciosa e/ou parasitária composição a base de antígeno de T cruzi utilização do antígeno derivado de microorganismo causador de doença infecciosa e/ou parasitária em testes sorológicos e vacinas utilização de antigeno derivado de T cruzi causador de doença de chagas em teste sorológico e vacinas processo para detecção de anticorpos anti antigeno de microorganismo causador de doença infecciosa e/ou parasitária e kit para sorodiagnóstico confirmatório para doença infecciosa e/ou parasitária
FR2825633B1 (fr) * 2001-06-11 2005-12-16 Bio Veto Tests Bvt Complexe vaccinal therapeutique destine a la prevention et au traitement des leishmanioses et des infections a microorganismes pathogenes intracellulaires chez le mammifere
FR2862313B1 (fr) * 2003-11-19 2006-02-24 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
FR2863272B1 (fr) * 2003-11-19 2006-06-09 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
US20050176144A1 (en) * 2004-02-06 2005-08-11 O'daly Jose A. Culture media compositions free of fetal bovine serum
FR2881752B1 (fr) 2005-02-10 2009-07-31 Inst Rech Pour Le Dev I R D Et Moyens pour l'obtention de promastigotes de leishmanies avirulents, promastigotes obtenus et leurs applications
DE102006041388A1 (de) * 2006-08-29 2008-03-20 Fachhochschule Jena Nährmedium und Verfahren zur Kultivierung eines Protozoan zu hohen Zelldichten mit hohen spezifischen Wachstumsraten
FR3014103B1 (fr) 2013-11-29 2019-08-16 Institut De Recherche Pour Le Developpement (Ird) Composition vaccinale pour la prevention et/ou le traitement de leishmanioses, peptides immunogenes et procede d'obtention
FR3081870B1 (fr) 2018-05-30 2024-04-19 Institut De Rech Pour Le Developpement Ird Epitopes, composes peptidiques mono-ou multiepitopiques et vaccins contre la leishmanie
BR102018067339A2 (pt) 2018-08-31 2021-11-16 Fundação Oswaldo Cruz Método para detectar anticorpos contra leishmania em uma amostra biológica canina, kit para detecção de infecção por leishmania em uma amostra biológica, e uso de lipofosfoglicano de leishmania

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US399743A (en) * 1889-03-19 Peters
FR1518449A (fr) * 1967-04-12 1968-03-22 Vnii Antibiotikov Procédé de culture des leishmanies
US3911097A (en) * 1973-08-07 1975-10-07 Research Corp Antigenic preparation suitable for diagnosis of chronic chagas disease
US3993743A (en) * 1973-08-07 1976-11-23 Research Corporation Method for diagnosis of Chagas' disease
EP0093774A1 (en) * 1981-11-17 1983-11-16 Brigham And Women's Hospital Monoclonal antibodies against leishmania
DE3581288D1 (de) * 1984-10-01 1991-02-14 Pasteur Institut Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
US4687666A (en) * 1985-02-19 1987-08-18 Ministerio De Sanidad Y Asistencia Social Instituto Venezolano De Investigationes Cientificas Vaccine for Leishmaniasis
GB8921937D0 (en) * 1989-09-28 1989-11-15 Howard Michael K Diagnostic reagents for leishmaniasis
JPH07504801A (ja) * 1991-08-06 1995-06-01 ザ　ワールド　ヘルス　オーガニゼイション Ｄｎａの単離方法
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies

Also Published As

Publication number Publication date
US7317094B2 (en) 2008-01-08
US20030059860A1 (en) 2003-03-27
WO1994026899A1 (fr) 1994-11-24
EP0698099A1 (fr) 1996-02-28
FR11C0040I1 (https=) 2011-10-14
US20030138461A1 (en) 2003-07-24
DE122011100046I1 (de) 2012-01-19
CA2162555A1 (fr) 1994-11-24
EP0698099B1 (fr) 2005-07-13
FR11C0040I2 (fr) 2012-06-22
FR2705358A1 (fr) 1994-11-25
US7282210B2 (en) 2007-10-16
US6458581B1 (en) 2002-10-01
US20030068690A1 (en) 2003-04-10
DE69434424T2 (de) 2006-04-20
DE69434424D1 (de) 2005-08-18
CA2162555C (fr) 2011-07-12
FR2705358B1 (fr) 1995-08-04
AU6800094A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
Soong et al. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis
ES2640614T3 (es) Plasmodium purificado y composiciones de vacuna
Li et al. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice
US4767622A (en) Method and materials for development of immunological responses protective against malarial infection
ES2313719T3 (es) Productos extracelulares abundantes y procedimiento de produccion y uso de los mismos.
ES2245776T3 (es) Procedimiento de cultivo in vitro de diferentes estadios de parasitos tisulares.
US4596707A (en) Babesia parasite antigen useful in vaccine and diagnostic reagent
Yang et al. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2
JP2617946B2 (ja) コクシジウム症ワクチン
Frommel et al. Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice
ES2260440T3 (es) Complejo de vacuna para prevenir y tratar la leishmaniasis.
KR100553646B1 (ko) 말라리아원충 항원 폴리펩티드 에스이36, 그 정제방법,그리고 이것으로부터 얻어지는 항원을 이용하는 백신 및진단제
US9346862B2 (en) Canine babesiosis vaccine antigen
ES2297025T3 (es) Mezcla vacunal terapeutica destinada a prevenir y tratar afecciones en mamiferos.
EP0136932A2 (en) Method and materials for development of immunological responses protective against malarial infection
ES2287145T3 (es) Aislado de neospora caninum.
SUDHAKAR ASSESSMENT OF IRRADIATION ATTENUATED INDUCED PROTECT IVE IMMUNE RESPONSE IN MICE
Taweenan Vaccination against Toxoplasmosis
Whalen DNA-based immunization and the immune response to the hepatitis B surface antigen
O'Donovan Erythrocyte invasion by the rodent malaria Plasmodium chabaudi chabaudi
Haddow Proteomic and immunochemical study of the tsetse fly'Glossina morsitans morsitans' midgut and salivary gland
Ristic et al. Immune responses and protection in bovine anaplasmosis and babesiosis.
US20080206285A1 (en) Compositions and methods for treatment and prevention of leishmaniasis